Prognosis
Trump Pushes an Unproven Coronavirus Drug, and Patients Stock Up
- ‘What do we have to lose?’ Trump asks, touting malaria drug
- Experts raise doubts about small study of hydroxychloroquine
This article is for subscribers only.
A tiny trial of a malaria drug may or may not have helped several patients in France fight off their coronavirus infections. The FDA has said it needs more study. Some expert doctors are skeptical. President Donald Trump is all for it.
On Saturday, Trump again promoted the drug at a White House briefing, and retweeted a post about a small scientific study that has been making the rounds for several days. It followed Trump’s comments Friday that the drug, hydroxychloroquine, was a “game changer,” that “we’re going to be able to make that drug available almost immediately,” and noting that patients could get it from their doctor.